PROTECT IRON Trademark

Trademark Overview

On Tuesday, June 23, 2015, a trademark application was filed for PROTECT IRON with the United States Patent and Trademark Office. The USPTO has given the PROTECT IRON trademark a serial number of 86671610. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, April 26, 2023. This trademark is owned by Gil Pharmaceutical Corp.. The PROTECT IRON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations containing iron for the prevention and treatment of blood disorders; Vitamin supplements containing iron
protect iron

General Information

Serial Number86671610
Word MarkPROTECT IRON
Filing DateTuesday, June 23, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, April 26, 2023
Registration Number5061951
Registration DateTuesday, October 18, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations containing iron for the prevention and treatment of blood disorders; Vitamin supplements containing iron
Disclaimer with Predetermined Text"IRON"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 29, 2015
Primary Code005
First Use Anywhere DateWednesday, November 3, 2010
First Use In Commerce DateWednesday, November 3, 2010

Trademark Owner History

Party NameGil Pharmaceutical Corp.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPonce 00716
PR
Party NameGil Pharmaceutical Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPonce 00732
PR
Party NameGil Pharmaceutical Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPonce 00732
PR

Trademark Events

Event DateEvent Description
Wednesday, April 26, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, April 26, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, April 26, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 18, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, October 18, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 18, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, August 2, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 2, 2016PUBLISHED FOR OPPOSITION
Wednesday, July 13, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 30, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 28, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 27, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 27, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 29, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 29, 2016NON-FINAL ACTION E-MAILED
Tuesday, March 29, 2016NON-FINAL ACTION WRITTEN
Tuesday, March 15, 2016PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, March 15, 2016WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, February 29, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 27, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 26, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 26, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 27, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 27, 2015NON-FINAL ACTION E-MAILED
Thursday, August 27, 2015NON-FINAL ACTION WRITTEN
Thursday, August 27, 2015ASSIGNED TO EXAMINER
Monday, June 29, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 26, 2015NEW APPLICATION ENTERED

Related Keywords

iron protect containing disorders vitamin supplements blood prevention preparations pharmaceutical treatment